EUCTR2004-004845-17-IT进行中（未招募）不适用
PHASE II STUDY ON PACLITAXEL-GEMCITABINE IN RECURRENT OVARIAN CANCER
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年8月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
未知
不适用
PHASE III STUDY OF GEMCITABIN WITH PACLITAXEL VERSUS PACLITAXEL IN PATIENTS WITH NON-RESECTIOUS, METASTASIC OR LOCALLY ADVANCED BREAST CANCER-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-059-01ELI LILLY INTERAMERICA INC.,
进行中（未招募）
不适用
PHASE II TRIAL OF PACLITAXEL, GEMCITABINE AND CISPLATIN IN PATIENTS WITH RELAPSING GERM CELL CANCER AFTER FIRST LINE CHEMOTHERAPY - relapse cis-tax-gem·The primary objective of this study is to investigate the combination of cisplatin/gemcitabine/paclitaxel, with respect to progression free survival in patients with germ cell tumours previously treated with BEP.MedDRA version: 9.1Level: LLTClassification code 10018204Term: Germ cell cancer NOSEUCTR2007-000618-35-DKRigshospitalet25
进行中（未招募）
1 期
PHASE II TRIAL OF PACLITAXEL, GEMCITABINE AND CISPLATIN IN PATIENTS WITH RELAPSING GERM CELL CANCER AFTER FIRST LINE CHEMOTHERAPY - relapse cis-tax-gemEUCTR2007-000618-35-SKATIONAL CANCER INSTITUTE25
进行中（未招募）
不适用
PHASE II TRIAL OF PACLITAXEL, GEMCITABINE AND CISPLATIN IN PATIENTS WITH RELAPSING GERM CELL CANCER AFTER FIRST LINE CHEMOTHERAPY - relapse cis-tax-gemEUCTR2007-000618-35-NLRigshospitalet25
未知
2 期
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinomaadvanced urothelial carcinomaJPRN-UMIN000001979Cancer Institute Hospital, Japanese Foundation for Cancer Research30